Skip to content
777 Sourcing.

Capability

clinical trials (Phase 1/2)

Suppliers
1
States & provinces
1
Countries
1

1 clinical trials (phase 1/2) supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CCKR THERAPEUTICS INC

RALEIGH, NC

CCKr Therapeutics is a drug development company focused on transforming GI cancer and fibrosis treatment. Its lead asset, Proglumide, is a small molecule repurposed drug with oral bioavailability that antagonizes the CCK-B receptor and blocks CCK-A and CCK-B receptors. Target indications include pancreatic cancer, chronic pancreatitis, liver fibrosis, and pain management. The company reports early Phase 1 results and ongoing Phase 1/2 trials, with fast-track potential.

drug developmentregulatory strategy

Compiled from public sources

Related capabilities

Other processes offered by the shops that list clinical trials (Phase 1/2).

Browse all capabilities